Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 08:01 ET | Source: Paratus Sciences Corporation

Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026

PS-1001 is a potent, long-acting inflammasome inhibitor. New data support its therapeutic promise for a wide range of chronic inflammatory diseases.